Optimized lipid nanoparticles enable effective CRISPR/Cas9-mediated gene editing in dendritic cells for enhanced immunotherapy
aKey Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Institute of Immunology, The First Hospital, Jilin University, Changchun 130061, China
bInternational Center of Future Science, Jilin University, Changchun 130015, China
cBeijing National Laboratory for Molecular Science, CAS Key Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry Chinese Academy of Sciences (ICCAS), Beijing 100190, China
dNational-local Joint Engineering Laboratory of Animal Models for Human Diseases, Changchun 130062, China
eState Key Laboratory of Supramolecular Structure and Materials, Jilin University, Changchun 130012, China
fUniversity of Chinese Academy of Sciences, Beijing 100049, China
gState Key Laboratory of Kidney Diseases, Chinese PLA General Hospital, Beijing 100143, China
* Corresponding authors.
收起